The use of wastewater surveillance to estimate SARS-CoV-2 fecal viral shedding pattern and identify time periods with intensified transmission.

Publication date: Mar 24, 2025

Wastewater-based surveillance is an important tool for monitoring the COVID-19 pandemic. However, it remains challenging to translate wastewater SARS-CoV-2 viral load to infection number, due to unclear shedding patterns in wastewater and potential differences between variants. We utilized comprehensive wastewater surveillance data and estimates of infection prevalence (i. e., the source of the viral shedding) available for New York City (NYC) to characterize SARS-CoV-2 fecal shedding pattern over multiple COVID-19 waves. We collected SARS-CoV-2 viral wastewater measurements in NYC during August 31, 2020 – August 29, 2023 (N = 3794 samples). Combining with estimates of infection prevalence (number of infectious individuals including those not detected as cases), we estimated the time-lag, duration, and per-infection fecal shedding rate for the ancestral/Iota, Delta, and Omicron variants, separately. We also developed a procedure to identify occasions with intensified transmission. Models suggested fecal viral shedding likely starts around the same time as and lasts slightly longer than respiratory tract shedding. Estimated fecal viral shedding rate was highest during the ancestral/Iota variant wave, at 1. 44 (95% CI: 1. 35 – 1. 53) billion RNA copies in wastewater per day per infection (measured by RT-qPCR), and decreased by around 20% and 50-60% during the Delta wave and Omicron period, respectively. We identified around 200 occasions during which the wastewater SARS-CoV-2 viral load exceeded the expected level in any of the city’s 14 sewersheds. These anomalies disproportionally occurred during late January, late April-early May, early August, and from late-November to late-December, with frequencies exceeding the expectation assuming random occurrence (P 

Open Access PDF

Concepts Keywords
August COVID-19
December COVID-19
Nyc Feces
Pandemic Humans
Viral New York City
SARS-CoV-2
Time Factors
Transmission
Variant
Viral Load
Viral shedding pattern
Virus Shedding
Wastewater
Wastewater
Wastewater surveillance
Wastewater-Based Epidemiological Monitoring

Semantics

Type Source Name
disease MESH viral shedding
disease MESH COVID-19 pandemic
disease MESH viral load
disease MESH infection
disease IDO infection prevalence
disease MESH anomalies
pathway REACTOME Reproduction
drug DRUGBANK Water
drug DRUGBANK Ademetionine
disease MESH Emergency
drug DRUGBANK Fenamole
drug DRUGBANK Timonacic
disease IDO assay
drug DRUGBANK Esomeprazole
drug DRUGBANK Hyaluronic acid
drug DRUGBANK 1D-myo-inositol 1 4 5-trisphosphate
drug DRUGBANK Coenzyme M
disease MESH uncertainty
drug DRUGBANK Hexocyclium
drug DRUGBANK Stavudine
disease MESH death
disease MESH reinfections
drug DRUGBANK Piroxicam
disease IDO ribonucleic acid
disease MESH Allergy
disease MESH Infectious Diseases
disease IDO role
drug DRUGBANK Methyl isocyanate
drug DRUGBANK Trinitrotoluene
drug DRUGBANK Guanosine
disease IDO acute infection
disease IDO cell
disease IDO symptom

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *